Potential Role of Tranexamic Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation

JAMA Dermatol. 2024 Feb 1;160(2):239-240. doi: 10.1001/jamadermatol.2023.5470.

Authors

David A Hashemi¹, Jordan V Wang^{1

2}, Roy G Geronemus^{1

3}

Affiliations

¹ Laser & Skin Surgery Center of New York, New York.
² Laser & Skin Surgery Center of Pennsylvania, Devon.
³ The Ronald O. Perelman Department of Dermatology, New York University Langone Health, New York.

PMID: 38231520
DOI: 10.1001/jamadermatol.2023.5470

No abstract available

MeSH terms

Humans
Hyperpigmentation* / diagnosis
Hyperpigmentation* / therapy
Laser Therapy*
Low-Level Light Therapy*
Rejuvenation
Skin Aging*
Tranexamic Acid* / therapeutic use
Treatment Outcome

Substances

Tranexamic Acid